Clinical trials
Phase 4 Hyperparathyroidism, Secondary trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott | 4 |
| Genzyme, a Sanofi Company | 4 |
| Duke University | 1 |
| Emory University | 1 |
| Nabi Biopharmaceuticals | 1 |
| Salem Veterans Affairs Medical Center | 1 |
| University of Colorado, Denver | 1 |
| Washington University School of Medicine | 1 |
| Weill Medical College of Cornell University | 1 |
| Winthrop University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperparathyroidism, Secondary | 16 |
| Renal Insufficiency, Chronic | 7 |
| Kidney Failure, Chronic | 3 |
| Renal Insufficiency | 3 |
| Hypercalcemia | 2 |
| Hyperphosphatemia | 2 |
| Vitamin D Deficiency | 2 |
| Arteriosclerosis | 1 |
| Calcinosis | 1 |
| Obesity | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.